参议员对600亿比索资金回归菲律宾健康保险公司表示欢迎

在最高法院裁定将资金转入国库违宪后,参议员们对菲律宾健康保险公司(PhilHealth)收回600亿比索超额资金表示欢迎。

参议员们昨日对菲律宾健康保险公司(PhilHealth)在最高法院裁定将其资金转入国库的行为违宪后,收回600亿比索“超额资金”表示欢迎。

参议员皮娅·卡耶塔诺(Pia Cayetano)称此举是“健康事业和菲律宾人民的胜利”,并表示国家保险公司的资金应被用于承担贫困患者的自费开支,而不是被扣留在国库中。卡耶塔诺说:“PhilHealth必须确保这些资金严格按照法律使用,以解决我们人民紧迫的健康需求。”

《全民健康保障法》的起草人之一、参议员JV·埃赫西托(JV Ejercito)表示,最高法院的命令应提醒人们,医疗保健资金只能用于其既定用途。参议员罗伦·勒加达(Loren Legarda)指出,与政府未使用的2203.9亿比索医疗资金(其中包括1134.4亿比索的烟酒税收入)相比,这些超额资金数额较小。

相关文章

Symbolic illustration of Colombia's Constitutional Court ordering $25B tax refund, with money flowing to governors amid ruling.
AI 生成的图像

Constitutional Court orders return of $25 billion collected during emergency

由 AI 报道 AI 生成的图像

Colombia's Constitutional Court declared Legislative Decree 1474 of 2025 unconstitutional and ordered the Dian to return about $25 billion collected from emergency economic taxes in December. The Dian confirmed it will comply and implement measures within 30 days. Governors welcomed the ruling for easing regional finances.

The Philippine Health Insurance Corp. confirmed that P60 billion has been returned to PhilHealth from the National Treasury. The agency said the funds will support efforts to expand and improve healthcare services.

由 AI 报道

Ombudsman Jesus Crispin Remulla has revealed a kickback scheme in private hospitals involving PhilHealth personnel and fraudulent billings. Patients are told their bills are not covered by PhilHealth, leading them to pay cash, after which hospitals alter receipts to claim PhilHealth payment. He urged patients to file complaints against those involved.

The Supreme Court held its first oral arguments on April 7 on petitions challenging unprogrammed appropriations in the 2024, 2025, and 2026 national budgets. Invited experts as amici curiae presented divided views on their legality and implications. Some warned of weakened transparency, while others defended their necessity.

由 AI 报道

The Court of Appeals has affirmed the dismissal from government service of former overall deputy ombudsman Warren Rex Liong over his role in the alleged overpriced procurement of personal protective equipment from Pharmally Pharmaceutical Corp. during the COVID-19 pandemic. The CA's Third Division denied his petition against the Ombudsman's order for lack of merit.

此网站使用 cookie

我们使用 cookie 进行分析以改进我们的网站。阅读我们的 隐私政策 以获取更多信息。
拒绝